Centene Corporation

Company Overview

Business Model: Centene Corporation is a leading managed care company focused on transforming the health of underserved populations by offering affordable and high-quality products. The Company primarily generates revenue through managed healthcare products and services across Medicaid, Medicare (including Medicare Prescription Drug Plans), and the Health Insurance Marketplace. Its operational model emphasizes a local approach, utilizing state-based plans and local teams to deliver culturally sensitive healthcare services and address social determinants of health such as food insecurity, housing instability, and transportation. Centene Corporation leverages data and insights to personalize care, improve outcomes, and enhance the affordability and effectiveness of the healthcare system.

Market Position: Centene Corporation is the nation's largest managed care company focused on underserved populations. As of December 31, 2025, it is the largest Medicaid insurer, serving 12.5 million members in 30 states, and the largest Marketplace insurer, serving 5.5 million members across 29 states under the Ambetter Health brand. The Company is also the largest stand-alone Medicare Prescription Drug Plan (PDP) provider, with 8.1 million members in 50 states and the District of Columbia. Its Medicare Advantage business features one of the highest concentrations of Dual Eligible Special Needs Plans (D-SNP) members among its peers, aligning with its focus on complex, low-income populations. Centene Corporation's competitive strengths include its scale, diversified offerings, strong provider relationships, and commitment to quality.

Recent Strategic Developments:

• Divestitures: Centene Corporation signed a definitive agreement in December 2025 to divest its remaining Magellan Health businesses. This follows the completion of the divestiture of Circle Health Group in January 2024 and Collaborative Health Systems in October 2024.
• Medicare Part D Expansion: Strategic bid positioning for 2026 resulted in bids below benchmarks for all 34 Centers for Medicare and Medicaid Services (CMS) regions, leading to an increase to over 8.7 million PDP members as of January 1, 2026.
• Marketplace Adjustments: During the third quarter of 2025, Centene Corporation implemented corrective pricing actions for 2026 in states covering 95% of its Marketplace membership, in response to an evolving regulatory and market environment and a higher projected baseline of Marketplace morbidity. The Ambetter Health brand expanded its geographic footprint by adding 60 new counties across 10 states in 2025.
• ICHRA Growth: Ambetter Health Solutions, the Company's off-exchange marketplace business offerings designed for Individual Coverage Health Reimbursement Arrangement (ICHRA) membership, expanded its presence from 6 states in 2025 to 13 states in 2026.
• Medicaid Contract Wins: Secured new or renewed Medicaid managed care contracts in Iowa, Mississippi, Florida (expanded Statewide Medicaid Managed Care program), Kansas, Michigan, and New Hampshire during 2024-2025.
• Technology Integration: Utilizes artificial intelligence (AI), Machine Learning (ML), and predictive modeling to enhance operational efficiencies, lower costs, and advance value-based care, while maintaining a "Humans in the Loop" approach to mitigate bias.

Geographic Footprint: Centene Corporation operates extensively across the United States. As of December 31, 2025, it serves Medicaid members in 30 states, Medicare Advantage members in 32 states, Medicare Prescription Drug Plan members in all 50 states and the District of Columbia, and Health Insurance Marketplace members in 29 states. Medicaid contracts in Florida and New York individually contributed approximately 10% or more of the Company's consolidated Medicaid premium revenues in 2025.

Financial Performance

Revenue Analysis

Profitability Metrics:

• Gross Margin: 8.1%
• Operating Margin: -3.9%
• Net Margin: -3.4%

Investment in Growth:

• R&D Expenditure: Not explicitly disclosed as a separate line item.
• Capital Expenditures: $0.8 billion ($767 million)
• Strategic Investments: Capital expenditures primarily focused on system enhancements and computer hardware/software. The Company also invests in data and analytics capabilities to improve health outcomes.

Business Segment Analysis

Medicaid

Financial Performance:

• Revenue: $110.4 billion (+9% YoY)
• Gross Margin: $5.7 billion (-9% YoY)
• Key Growth Drivers: Revenue growth was primarily driven by increased premium tax revenue and rate increases, partially offset by lower membership due to ongoing redeterminations. Gross margin decreased due to higher medical costs, particularly in behavioral health, home health, and high-cost drugs.

Product Portfolio: Includes Temporary Assistance for Needy Families (TANF), Medicaid Expansion, Aged, Blind or Disabled (ABD), Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, and other state-based programs. Medicare-Medicaid Plans (MMP) concluded on December 31, 2025, as CMS transitions to Dual Eligible Special Needs Plans (D-SNPs) based integration.

Market Dynamics: Centene Corporation is the nation's largest Medicaid health insurer, serving 12.5 million members in 30 states. The One Big Beautiful Bill Act (OBBBA), passed in July 2025, is expected to impact Medicaid Expansion programs through work requirements, more frequent eligibility redeterminations, and cost-sharing, potentially increasing the morbidity of the population. The OBBBA may also reduce federal funding for Medicaid and restrict payments to "prohibited entities." New York intends to terminate its Essentials Plan-5 by July 1, 2026.

Medicare

Financial Performance:

• Revenue: $37.2 billion (+62% YoY)
• Gross Margin: $3.0 billion (+15% YoY)
• Key Growth Drivers: Revenue and gross margin increases were primarily driven by significant growth in Medicare Prescription Drug Plan (PDP) premium yield and membership, supported by strong 2026 bid positioning. Program changes resulting from the Inflation Reduction Act (IRA) also led to a meaningful shift in cost-sharing responsibilities and increased premiums. These gains were partially offset by a 10% decline in Medicare Advantage membership, consistent with strategic positioning.

Product Portfolio: Includes Medicare Advantage (1.0 million members across 32 states, primarily under the Wellcare brand), Dual Eligible Special Needs Plans (D-SNPs), Medicare Prescription Drug Plans (PDP) (8.1 million members in 50 states and D.C.), and Medicare Supplement.

Market Dynamics: Centene Corporation is the country's largest stand-alone PDP provider. The IRA, effective in 2025, eliminated the coverage gap and capped members' annual out-of-pocket costs at $2,000 (increasing to $2,100 in 2026), leading to increased premiums for PDPs. The Company participated in the Medicare Part D Premium Stabilization Demonstration program in 2025, which included narrowed risk corridor thresholds, but these were eliminated for 2026. CMS regulations are promoting greater alignment for dual-eligible members, requiring integrated care through D-SNPs beginning in 2030, with certain restrictions starting in 2027. Approximately 60% of the Company's Medicare Advantage membership was enrolled in plans rated 3.5 stars or higher as of October 2025, impacting 2027 revenues.

Commercial

Financial Performance:

• Revenue: $42.0 billion (+25% YoY)
• Gross Margin: $5.1 billion (-33% YoY)
• Key Growth Drivers: Revenue growth was primarily driven by a 26% increase in Health Insurance Marketplace membership, resulting from an expanded geographic footprint and strong open enrollment. However, gross margin significantly decreased due to lower estimated risk adjustment revenue and increased Marketplace medical costs.

Product Portfolio: Includes the Health Insurance Marketplace product (Ambetter Health brand), individual and commercial group, Individual Coverage Health Reimbursement Arrangement (ICHRA), and other off-exchange individual products. Ambetter Health Solutions, offering ICHRA-compatible plans, expanded to 13 states in 2026.

Market Dynamics: Centene Corporation is the largest Marketplace carrier. The Marketplace Integrity and Affordability Final Rule (June 2025) repealed the Special Enrollment Period for those under 150% of the Federal Poverty Level (FPL) and introduced stricter income verification. The expiration of Enhanced Advance Premium Tax Credits (APTCs) at the end of 2025 and additional restrictions from the OBBBA are anticipated to reduce 2026 Marketplace membership and increase the overall morbidity of the population.

Other

Financial Performance:

• Revenue: $5.1 billion (+4% YoY)
• Gross Margin: $0.4 billion (-23% YoY)
• Key Growth Drivers: Gross margin decreased primarily due to the divestiture of Circle Health Group in the first quarter of 2024 and the expiration of the TRICARE Managed Care Support Contract in December 2024.

Product Portfolio: Includes specialty pharmacy operations (AcariaHealth), vision and dental services, clinical healthcare (Community Medical Group, Denova Collaborative Health), behavioral health (Magellan Health, Inc. - remaining businesses under definitive divestiture agreement), and centralized services.

Capital Allocation Strategy

Shareholder Returns:

• Share Repurchases: In 2025, Centene Corporation repurchased 6.7 million shares of common stock for $400 million under its stock repurchase program. An additional $48 million was spent on repurchases related to income tax withholding upon stock grant vesting.
• Dividend Payments: Not explicitly disclosed as paid to external shareholders in the filing.
• Future Capital Return Commitments: As of December 31, 2025, $1.8 billion remained authorized under the stock repurchase program, with no specified duration. In February 2026, the Board of Directors authorized an additional $1.0 billion increase to the senior note debt repurchase program, bringing the total available to $1.5 billion.

Balance Sheet Position:

• Cash and Equivalents: $17.9 billion
• Total Debt: $17.4 billion
• Net Cash Position: $0.5 billion
• Credit Rating: The applicable margin for the Revolving Credit Facility is based on Centene Corporation's corporate debt obligations rating by S&P and Moody's.
• Debt Maturity Profile: As of December 31, 2025, the Company had $15.5 billion in senior notes outstanding, with maturities ranging from December 2027 to August 2031. The Term Loan Facility of $2.0 billion matures on March 5, 2030.

Cash Flow Generation:

• Operating Cash Flow: $5.1 billion
• Free Cash Flow: Not explicitly stated.
• Cash Conversion Metrics: Days in claims payable was 46 days in 2025, compared to 53 days in 2024.

Operational Excellence

Production & Service Model: Centene Corporation provides managed healthcare services through a full spectrum of products, emphasizing a local approach with state-based plans and community-embedded teams. This model facilitates access to high-quality, culturally sensitive healthcare. The Company has developed specialized care management, service coordination, and crisis prevention/response programs for complex populations, particularly within Medicaid and foster care, aiming to improve health outcomes and reduce preventable emergency department utilization. Quality improvement is foundational, with initiatives focused on standardizing processes, expanding advanced analytics, enhancing data availability for care gap identification, and strengthening local provider relationships. Centene Corporation pursues accreditation from independent organizations like the National Committee for Quality Assurance (NCQA) to validate its quality objectives. The Company engages providers through performance tools, an Integrated Care Model (single care manager for holistic care coordination), and a Provider Portal for administrative and analytical support. It is committed to value-based contracting, including pay-for-performance, shared savings, shared risk, and full risk models, prioritizing partnerships over direct ownership of providers.

Supply Chain Architecture: Key Suppliers & Partners:

• Pharmacy Benefits Management: Contracts with third-party pharmacy benefits managers (PBMs) for pharmacy services.
• Medical Management: Engages third-party vendors for medical management and other member-related services.
• Technology Services: Utilizes third-party vendors for technology services, including artificial intelligence (AI) solutions.
• Provider Networks: Establishes extensive networks of primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers.
• Community-Based Organizations: Collaborates with community-based organizations to support members and address social determinants of health.

Facility Network:

• Manufacturing: Not applicable as Centene Corporation is a managed care company.
• Corporate Office: Owns its corporate headquarters buildings and land in St. Louis, Missouri.
• Health Plans & Claims Processing: Generally leases office space in the states where its health plans and claims processing facilities operate, fulfilling regulatory requirements for local presence.
• Research & Development: Not explicitly detailed as separate facilities, but R&D is integrated into technology and innovation efforts.
• Distribution: Not applicable.

Operational Metrics:

• Health Benefits Ratio (HBR): 91.9% (2025)
• Selling, General and Administrative (SG&A) Expense Ratio: 7.4% (2025)
• Adjusted SG&A Expense Ratio: 7.4% (2025)
• Days in claims payable: 46 days (2025)
• Medicare Advantage Star Ratings: Approximately 60% of Medicare Advantage membership enrolled in plans rated 3.5 stars or higher as of October 2025.

Market Access & Customer Relationships

Go-to-Market Strategy: Centene Corporation employs a multi-channel approach to market access, leveraging its strong local presence and diversified product portfolio. Distribution Channels:

• Direct Sales: Engages directly with customers, particularly in the Health Insurance Marketplace and Medicare segments.
• Channel Partners: Utilizes broker distribution networks to reach potential members for its Medicare and Marketplace products.
• Digital Platforms: Employs online sales channels and e-commerce initiatives to facilitate enrollment in its digital platforms.

Customer Portfolio: Enterprise Customers:

• Government Entities: The primary customer base consists of federal and state governments, through contracts for Medicaid, Medicare, and Health Insurance Marketplace programs.
• Employer Groups: Offers commercial health insurance products to both large and small employer groups in specific markets.
• Customer Concentration: Medicaid contracts with the states of Florida and New York each accounted for approximately 10% or more of the Company's consolidated Medicaid premium revenues in 2025, indicating a degree of customer concentration.

Geographic Revenue Distribution:

• Medicaid: 57% of total external revenues in 2025.
• Commercial: 21% of total external revenues in 2025.
• Medicare: 19% of total external revenues in 2025.
• Other: 3% of total external revenues in 2025.
• Growth Markets: The Company is actively expanding its Individual Coverage Health Reimbursement Arrangement (ICHRA) offerings, with Ambetter Health Solutions operating in 13 states in 2026, up from 6 states in 2025. Ambetter Health also expanded its geographic footprint by 60 new counties across 10 states in 2025.

Competitive Intelligence

Market Structure & Dynamics

Industry Characteristics: Centene Corporation operates in a highly competitive, dynamic, and rapidly evolving health service industry. This environment is characterized by ongoing business consolidations, strategic partnerships, market pressures, and continuous regulatory and legislative changes at both federal and state levels. The Company primarily serves government-subsidized healthcare programs, including Medicaid, Medicare, and the Health Insurance Marketplace. The market presents significant growth opportunities, with CMS estimating Medicaid spending to grow at an average annual rate of 7% to $1.5 trillion by 2031, and Medicare spending at 8% to $1.9 trillion by 2031. There is also a notable opportunity to increase penetration of Medicare Advantage products, as over 40% of Medicare spend in 2024 was still in Medicare fee-for-service. CMS regulations are also driving greater alignment and integration for dual-eligible members, a population with significant unmet needs in integrated care plans.

Competitive Positioning Matrix:

Direct Competitors

Primary Competitors: Centene Corporation competes with numerous entities, including other managed care organizations (MCOs), traditional state Medicaid programs that reimburse providers on a fee-for-service basis, and emerging non-traditional entrants in the health service industry. The Company also faces competition from significant merger and acquisition activity within the managed care and complementary industries.

Emerging Competitive Threats: New market entrants, disruptive technologies (including advanced AI solutions), and shifts in the regulatory and political environment pose ongoing competitive threats.

Competitive Response Strategy: Centene Corporation maintains its competitive advantage by leveraging its substantial scale and diversified product offerings. The Company prioritizes building and maintaining strong provider relationships through collaborative approaches and value-based contracting models. A strong emphasis is placed on quality of care and services, with continuous efforts to achieve and maintain high quality ratings (e.g., Medicare Star ratings, Medicaid Health Plan Rating, Marketplace Quality Rating System). Its local market presence and focus on product innovation, such as Individual Coverage Health Reimbursement Arrangements (ICHRAs), are key to adapting to evolving consumer needs.

Risk Assessment Framework

Strategic & Market Risks

Market Dynamics:

• Medical Cost Trends: Failure to accurately identify and mitigate accelerating medical cost trends (e.g., increased demand, expanded access, high-cost pharmaceuticals, behavioral health, home health, high-cost drugs) and secure adequate rate adjustments could materially impact profitability.
• Pricing and Demand: Inability to accurately price or anticipate demand for Medicare and Health Insurance Marketplace products, or unforeseen changes in the competitive landscape, could adversely affect financial performance.
• Risk-Adjustment Systems: Reliance on risk-adjustment payment systems for government programs introduces estimation difficulties and potential for retroactive adjustments, which could materially affect revenue and results.
• Government Contract Risks: Unsuccessful bids for new contracts, failure to renew existing government contracts, or adverse findings from audits/investigations could significantly harm business operations and reputation.
• Medicare Program Specific Risks: Unique risks include challenges in designing attractive Medicare programs, negative audit outcomes, inadequate bids, contract modifications/terminations, and inability to maintain or improve quality Star ratings.
• ACA Changes: Significant legislative or judicial changes to the Affordable Care Act (ACA) and other government-sponsored healthcare programs, including the expiration of Enhanced Advance Premium Tax Credits (APTCs) and provisions of the One Big Beautiful Bill Act (OBBBA), could materially and adversely affect business, membership, and financial condition.

Operational & Execution Risks

Supply Chain Vulnerabilities:

• Third-Party Vendor Dependency: Reliance on third-party vendors for critical functions (e.g., pharmacy benefits management, medical management, technology services) exposes the Company to risks if these vendors fail to meet obligations, comply with regulations, or experience operational disruptions.
• State System Ineffectiveness: Inaccuracies or ineffectiveness in state-operated systems for eligibility, enrollment, or data provision could negatively impact membership, premium revenues, and financial results.
• Provider Network Management: Challenges in maintaining strong relationships with provider networks, contracting at competitive rates, or ensuring accurate provider directories could adversely affect profitability, regulatory compliance, and member access to care.
• Information Systems & Networks: Disruptions or failures in internal or third-party information systems and networks, including those related to AI and large language models, could lead to operational interruptions, data inaccuracies, and increased administrative expenses.
• Cybersecurity Incidents: A failure or breach of operational or security systems, networks, or infrastructure (internal or third-party), including cyber-attacks and data security incidents, could result in unauthorized data access, operational disruptions, reputational harm, and material financial or regulatory penalties.

Capacity Constraints:

• Staffing for Demand: Higher-than-anticipated demand for products could strain staffing resources, potentially impacting service levels, quality scores, and relationships with stakeholders.

Financial & Regulatory Risks

Market & Financial Risks:

• Investment Portfolio Losses: The Company's significant investment portfolio is exposed to interest rate, credit, liquidity, and market risks, which could lead to valuation declines and adversely affect results of operations or liquidity.
• Credit Market Conditions: Adverse credit market conditions could limit access to additional capital, impacting liquidity and funding for operations, debt obligations, and strategic initiatives.
• Substantial Indebtedness: The Company's substantial outstanding indebtedness ($17.4 billion as of December 31, 2025) and potential future borrowings could reduce financial flexibility, increase borrowing costs, and impose restrictive covenants.
• Dividend Restrictions: State insurance and HMO laws restrict the amount of dividends and distributions that subsidiaries can pay to the parent company without prior regulatory approval, potentially limiting funds available for corporate strategy.

Regulatory & Compliance Risks:

• Extensive Regulation: The highly regulated nature of the business means new laws, regulations, or changes in enforcement could necessitate operational restructuring, increase costs, or harm reputation.
• Fraud, Waste, and Abuse Laws: Non-compliance with federal and state fraud, waste, and abuse laws could lead to significant civil or criminal penalties, exclusion from government programs, and reputational damage.
• Data Privacy and Security Laws: Failure to comply with evolving data privacy and security laws (e.g., HIPAA, HITECH Act, Gramm-Leach-Bliley Act, CCPA) and contractual obligations could result in substantial costs, legal liability, regulatory investigations, and reputational harm.
• Tax Legislation/Challenges: Changes in tax legislation (e.g., OBBBA's impact on Medicaid MCO tax rates) or challenges to tax positions could adversely affect the Company's effective tax rate and cash flow.

Geopolitical & External Risks

Geopolitical Exposure:

• Government Funding Dependencies: Dependence on federal and state government funding for healthcare programs exposes the Company to risks from budgetary constraints, funding reductions, or delays in payments, which could materially affect operating cash flow and liquidity.
• External Events: Unexpected events such as acts of war or aggression could impact the ability to accurately predict and control healthcare costs.

Innovation & Technology Leadership

Research & Development Focus: Centene Corporation is committed to innovation, with a strategic focus on leveraging technology to improve healthcare delivery and outcomes. Core Technology Areas:

• Data and Analytics: The Company has an investment strategy aimed at increasing its capability to collect and analyze data and insights from diverse sources, including medical, vision, behavioral health claims, pharmacy data, and dental vendor data. This data is used to track utilization trends, identify health disparities, monitor quality of care, and evaluate program effectiveness.
• Artificial Intelligence (AI) & Machine Learning (ML): Centene Corporation utilizes AI, ML, and predictive modeling to lower costs, advance access to value-based care, and increase operational efficiencies for employees, members, vendors, and provider partners. The Company has developed policies and a governance structure to ensure responsible design, development, and use of AI, with a focus on mitigating harmful bias and maintaining "Humans in the Loop" for decision-making.
• Innovation Pipeline: The Company continuously develops innovative solutions and programs to address the evolving needs of its members and aims to redefine the healthcare experience.

Intellectual Property Portfolio: Not explicitly detailed in the provided text.

Technology Partnerships: Not explicitly detailed in the provided text, but the Company's "partnership mindset" extends to finding and maintaining the best partners, including those with innovative capabilities.

Leadership & Governance

Executive Leadership Team

Leadership Continuity: Centene Corporation maintains a robust talent infrastructure, including ongoing enterprise talent reviews, succession planning, career development planning, and comprehensive workforce analytics. Centene University offers customized leadership development programs to prepare its talent bench.

Board Composition: The Board of Directors holds primary oversight responsibility for enterprise-wide risk management. The Board Audit and Compliance Committee oversees IT risks, including cybersecurity, artificial intelligence, privacy, critical infrastructure, and disaster recovery. The Board Quality Committee oversees the Company's overall data and technology strategy. Both committees provide regular reports to the full Board, and management escalates significant cybersecurity events as appropriate. The Board and management also conduct tabletop cybersecurity crisis simulation exercises.

Human Capital Strategy

Workforce Composition: As of December 31, 2025, Centene Corporation had approximately 61,100 team members. The Company is committed to attracting, developing, and retaining diverse and skilled talent to execute its long-term business strategy.

Talent Management: Acquisition & Retention:

• Hiring Strategy: Talent advisors and hiring leaders recruit nationally to build a workforce with diverse perspectives and capabilities.
• Retention Metrics: Not explicitly detailed.
• Employee Value Proposition: Centene Corporation offers a pay-for-performance compensation philosophy and competitive benefits, including traditional healthcare, wellness programs, an employee assistance program, tuition reimbursement, a 401(k) retirement plan, an employee stock purchase plan, and comprehensive family support programs (adoption assistance, back-up dependent care, parental leave, caregiver leave). Parental leave provides six weeks of fully compensated time for caregivers, with an additional eight weeks for mothers, totaling up to 14 weeks of fully compensated maternity leave. The Company also offers paid community volunteer time.

Diversity & Development:

• Diversity Metrics: Not explicitly detailed, but the Company emphasizes building a workforce with a broad range of voices and experiences.
• Development Programs: Centene University provides scalable learning and development through digital tools, virtual learnings, and customized leadership programs. Performance reviews are dynamic and support continuous career growth.
• Culture & Engagement: The Company fosters a "One CenTeam" culture guided by values of accountability, courage, curiosity, trust, and service. An employee engagement tool gathers feedback, and Centene Professional Networks offer professional connections and leadership opportunities.
• Modernized Workforce: The majority of team members utilize remote and hybrid work arrangements, reflecting a modern work environment.

Environmental & Social Impact

Environmental Commitments: Centene Corporation's Corporate Sustainability Framework, overseen by the Board of Directors' Governance Committee, guides its responsible operations across economic, social, and environmental dimensions. The Company issues an annual Task Force on Climate-related Financial Disclosures (TCFD) Index report outlining its governance, strategy, risks, opportunities, and metrics related to managing climate change.

Supply Chain Sustainability: The Company's Corporate Responsibility Report highlights its commitment to responsible operations, which includes embedding inclusion and experiential intelligence throughout its business decisions and strategies.

Social Impact Initiatives: Centene Corporation's mission is to transform community health, focusing on identifying and removing barriers to health. Its programs and services are tailored to support whole-person care and address upstream drivers of health such as food insecurity, housing instability, unemployment, and access to transportation. The Company partners with organizations like the National Association of Community Health Centers to enhance value-based care adoption and improve maternal and child health outcomes. It issues an annual Corporate Responsibility Report and a SASB Index report, providing corporate sustainability disclosures to stakeholders.

Business Cyclicality & Seasonality

Demand Patterns:

• Seasonal Trends: The Medicare Advantage and Commercial segments typically experience seasonality, with a higher percentage of earnings in the first half of the year. This is because members tend to reach their deductibles and out-of-pocket maximums earlier in the year, leading to higher medical costs in the latter half. The Medicare Part D business also exhibits underlying seasonality.
• Economic Sensitivity: The Company's significant reliance on government-subsidized healthcare programs exposes it to economic sensitivity. Adverse economic conditions can lead to pressures on state budgets, potentially resulting in reduced or delayed funding, contraction of covered benefits, increased taxes and fees, or limited/no premium rate increases.
• Industry Cycles: Not explicitly detailed beyond general industry evolution.

Planning & Forecasting: Centene Corporation's planning and forecasting involve anticipating demand for its Health Insurance Marketplace and Medicare products, which are influenced by factors such as bid competitiveness, broker distribution channels, program integrity initiatives, and competitor entry/exit. The Company aims to ensure adequate operational resources and staffing to meet service level requirements.

Regulatory Environment & Compliance

Regulatory Framework: Centene Corporation's operations are extensively regulated at the local, state, and federal levels. This includes oversight by health and human services departments, Medicaid agencies, boards of pharmacy, departments of insurance, and departments of health. Industry-Specific Regulations:

• State Regulations: The Company is subject to state-specific laws and regulations covering premium taxes, prompt payment requirements, mandated coverage of drugs/services, medical loss ratios (MLR), disclosure requirements, and monitoring of provider groups.
• Federal Programs: Compliance with federal regulations is critical for Medicare programs (Parts A-D, Medicare Advantage, PDPs, D-SNPs, MMPs) under Title XVIII of the Social Security Act, and the Affordable Care Act (ACA).
• Medicaid Managed Care: Adherence to CMS final regulations (April 2016, May 2024) for Medicaid managed care is required, which establish minimum MLR standards (85%) and strengthen provisions related to network adequacy, access to care, enrollment, and quality oversight.
• Pharmacy Benefits: Pharmacy operations are subject to extensive federal, state, and local laws, with ongoing regulatory consideration for industry practices such as pharmacy ownership, rebates, formularies, and average wholesale prices.
• AI Regulation: The Company must comply with HHS transparency requirements for artificial intelligence (AI) and predictive algorithms used in certified health information technology (2023), and is monitoring emerging laws and standards concerning AI and automation.

Trade & Export Controls: Centene Corporation must comply with laws and regulations governing U.S. Government contracts.

Legal Proceedings: The Company is routinely involved in legal and regulatory proceedings, including compliance reviews and investigations by federal and state agencies related to claims payment, Medicare and Marketplace regulations (e.g., risk adjustment, prior authorizations, broker compensation), the False Claims Act, MLR calculations, provider directory accuracy, cybersecurity, HIPAA, and fraud, waste, and abuse laws.

• Federal Securities Class Action and Derivative Lawsuits: On July 9, 2025, a putative federal securities class action was filed, alleging false and misleading statements regarding 2025 earnings guidance. Five related derivative lawsuits were subsequently filed, alleging breach of fiduciary duties. The Company denies wrongdoing and is vigorously defending these claims.
• Bid Protests: Centene Corporation is currently protesting the results of Medicaid procurement awards in Texas and Georgia. A bid protest is also ongoing for the Pennsylvania Community HealthChoices program, and the Arizona Long Term Care System (ALTCS) rebid is expected in late summer 2026 due to a prolonged protest.

Tax Strategy & Considerations

Tax Profile:

• Effective Tax Rate: For the year ended December 31, 2025, Centene Corporation recorded an income tax benefit of $51 million on a pre-tax loss of $6.7 billion, resulting in an effective tax rate of 0.8%. The effective tax rate on adjusted earnings was 20.4%.
• Geographic Tax Planning: The Company is subject to tax laws in the U.S. (federal, state, and local) and other jurisdictions.
• Tax Reform Impact: The One Big Beautiful Bill Act (OBBBA), passed in July 2025, includes a requirement that states cannot impose higher tax rates on Medicaid MCOs than on commercial insurance by the end of the fiscal year 2026. If states increase tax rates for the Marketplace line of business in 2026, the Company cannot offset these increases by raising premiums, potentially impacting the profitability of its Marketplace products.

Insurance & Risk Transfer

Risk Management Framework: Centene Corporation maintains a system of prevention and detection controls through its security programs and generally performs data security due diligence on key service providers.

• Insurance Coverage: The Company maintains some third-party insurance coverage, including excess liability insurance. However, certain liabilities or types of damages, such as punitive damages, may not be covered, or insurers may dispute coverage or the amount of insurance may be insufficient.
• Risk Transfer Mechanisms: Not explicitly detailed beyond general insurance coverage.